Isabelle Heys

2024-06-12T14:02:56+01:00

Meet The Team

Isabelle Heys | ApconiX | Industry Placement Student

Isabelle Heys

Isabelle Heys is an industrial placement student from the Newcastle University studying for a BSc in Biochemistry.  They joined the Ion Channel Laboratory team and will be working on demonstrating the specific differences that exist between rodent and human seizurogenic responses.   Isabelle’s project will be focused on ion channels and a combination of bioinformatics and electrophysiological techniques.

Read more Isabelle Heys

Paul Carter

2024-06-12T14:04:12+01:00

Meet The Team

Paul Carter

Paul Carter

Paul has 30+ years’ experience in both CRO and pharmaceutical industries (AstraZeneca) as a study director/study monitor on a range of studies, including all delivery routes and species but specialising as an inhalation toxicologist.  For the last 10 years at AstraZeneca, Paul led the global strategic implementation of preclinical outsourcing of inhalation toxicology studies.  A recognised international expert in the field of inhalation toxicology/aerosol science, Paul has been an active committee member of the Association of Inhalation Toxicologists since 1987. Paul is a versatile toxicologist within the pharmaceutical arena and has all round knowledge of all processes involved in drug research and development.

Abigail Walker

2024-06-12T14:05:12+01:00

Meet The Team

Abigail Walker

Abigail Walker

MSc

Abigail Walker is a scientific writer with experience in toxicology, neuroscience, neurobiology and nutrition, having graduated from the University of Glasgow with a BSc and MSc in Neuroscience.  A keen communicator, she enjoys expanding her knowledge base, drawing out the key points in complex scientific subjects and working collaboratively in teams.

Joanne Wilson

2024-06-12T14:06:04+01:00

Meet The Team

Joanne Wilson

Joanne Wilson

Joanne has more than 20 years of experience as a DMPK scientist and project manager gained at AstraZeneca.  In this role, she led cross-functional teams to drive the optimal and efficient development of novel drugs. Joanne has worked across all therapy areas with a special expertise in oncology.  Joanne brings a blend of scientific expertise and project management skills to optimise drug discovery and development processes.

Read more here Joanne Wilson

Stacey Owen

2024-06-12T14:06:39+01:00

Meet The Team

Stacey Owen

Stacey Owen

Stacey is an experienced customer facing professional programme manager with extensive experience in nurturing and establishing long-term relationships to ensure optimal delivery.  She is an excellent communicator with the experience needed to manage complex projects with rapidly changing and competing priorities.  A true customer advocate, Stacey brings calmness and clarity to provide the best service possible, eliciting and listening to feedback to improve outcomes.

Read more here Stacey Owen

Sarah Pass

2024-06-12T13:59:05+01:00

Meet The Team

Sarah Pass

Dr Sarah Pass

Sarah is an experienced drug metabolism and pharmacokinetics (DMPK) consultant, having worked for almost 30 years in the pharmaceutical and CRO industries, providing a wide range of expertise to academia, biotechnology and pharmaceutical companies.  A collaborative project leader, Sarah has broad experience ranging from lead identification though to end of Phase II clinical development.  Sarah is passionate about making a difference to patients’ lives and delivering decision-making data to accelerate new drugs through the R&D pipeline.

Read more here Sarah Pass

Dr Craig Thomas

2024-06-12T14:07:12+01:00

Meet The Team

Dr Craig Thomas

Dr Craig Thomas

PhD

Craig has extensive expertise in toxicology, discovery research, competitive intelligence and due diligence spanning more than three decades. He began his career at the Marion Merrell Dow research institute where he worked in Cardiovascular and CNS discovery before joining Eli Lilly in 1996 where he focused on increasing the efficiency and predictability of early phase safety assessment. Building on this, he spent two years leading cross-functional due diligence then progressed to lead strategic competitive intelligence for neuroscience, including conducting drug target assessments.  Craig is passionate about the critical role toxicology plays in delivering innovative molecules with optimal risk-benefit profiles to address major unmet medical needs.

Read more here Dr Craig Thomas

Henry Bushell

2023-10-19T16:05:34+01:00

Meet The Team

Henry Bushell

Henry Bushell

Henry has a keen interest in economics and decided to acquire some business experience, joining ApconiX straight from sixth form college.  Playing an active role within business development, Henry hopes to gain an understanding of how businesses become and remain successful before going on to study economics at university.  An active mind and a willingness to take on new projects, Henry is well suited to the very busy, very demanding workload of a growing company.

Read more here Henry Bushell

William Humfrey

2024-06-12T14:07:42+01:00

Meet The Team

William Humfrey

William Humfrey

MSc

Will studied for an integrated master’s degree in biomedical science at the University of Sheffield where he gained understanding of human health, disease processes and developed both practical and written skills. Particularly enjoying literature searches, critical reviews, data analysis and report writing, Will is keen to learn new skills as part of the target safety assessment team.

Read more here William Humfrey

Michelle Blissett

2024-06-12T14:08:06+01:00

Meet The Team

Michelle Blissett

Michelle Blissett

MSc

With almost 20 years devoted to preclinical toxicology, Michelle has developed an excellent ability to conduct extensive literature searches, interrogating, analysing and interpreting data and has contributed to regulatory and scientific reports and produced numerous literature reviews.  As a Senior Toxicologist, Michelle has experience of clinical chemistry, haematology, cytogenetics and conducting preclinical studies for clients globally.  A collaborative and articulate communicator, Michelle has an aptitude for conveying complex scientific data in an accurate and concise manner.

Read more here Michelle Blissett

Go to Top